|Bid||3.7700 x 1100|
|Ask||3.7900 x 1100|
|Day's Range||3.7700 - 3.9300|
|52 Week Range||2.4000 - 8.4100|
|Beta (5Y Monthly)||2.42|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 05, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||5.21|
In this article we will check out the progression of hedge fund sentiment towards Calyxt, Inc. (NASDAQ:CLXT) and determine whether it is a good investment right now. We at Insider Monkey like to examine what billionaires and hedge funds think of a company before spending days of research on it. Given their 2 and 20 […]
Calyxt (CLXT) has been upgraded to a Zacks Rank 1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, today announced a research collaboration with NRGene® that includes the adoption of NRGene’s cloud-based genomics platform to support key Calyxt’s research projects. The genomics solutions are expected to allow for more comprehensive evaluations to accelerate trait discovery and breeding across multiple crops.